Stephen K. Doberstein, SVP & Chief Scientific Officer at NEKTAR THERAPEUTICS (NKTR), sold 4,852 shares at $82.94 ($402K) on 2018-02-16, disclosed to the SEC on 2018-02-20.
Open-market sale of $402k NKTR by SVP & Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $82.94 | 2,426 | $201K | 50.0% |
| 2 | $82.94 | 2,426 | $201K | 50.0% |
| Total | $82.94 avg | 4,852 | $402K | 100% |
| Filing → |
| NKTR | SELL | 2019-05-17 | $217K | — | Filing → |
| NKTR | SELL | 2019-02-21 | $281K | — | Filing → |
| NKTR | SELL | 2018-11-19 | $173K | — | Filing → |